Devansu Tewari

1.2k total citations
32 papers, 795 citations indexed

About

Devansu Tewari is a scholar working on Epidemiology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Devansu Tewari has authored 32 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Reproductive Medicine and 8 papers in Obstetrics and Gynecology. Recurrent topics in Devansu Tewari's work include Ovarian cancer diagnosis and treatment (11 papers), Cervical Cancer and HPV Research (8 papers) and Cancer Research and Treatments (5 papers). Devansu Tewari is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Cervical Cancer and HPV Research (8 papers) and Cancer Research and Treatments (5 papers). Devansu Tewari collaborates with scholars based in United States, Chile and Norway. Devansu Tewari's co-authors include Bradley J. Monk, Deborah K. Armstrong, Thomas J. Herzog, Ritu Salani, James Java, Maurie Markman, John K. Chan, Jerry E. Manning, David L. Fouts and Hans‐Ulrich Bernard and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Devansu Tewari

29 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devansu Tewari United States 12 381 236 219 202 182 32 795
Thomas Ehlen Canada 19 663 1.7× 320 1.4× 329 1.5× 248 1.2× 306 1.7× 35 1.5k
Mojca Eržen Italy 13 432 1.1× 181 0.8× 137 0.6× 177 0.9× 70 0.4× 34 691
Jean‐Jacques Baldauf France 16 487 1.3× 133 0.6× 268 1.2× 181 0.9× 66 0.4× 59 847
C. Meg McLachlin Canada 19 498 1.3× 117 0.5× 348 1.6× 289 1.4× 171 0.9× 45 989
Jan Pyman Australia 12 136 0.4× 119 0.5× 88 0.4× 133 0.7× 111 0.6× 20 525
Inger Gustavsson Sweden 19 888 2.3× 181 0.8× 341 1.6× 238 1.2× 360 2.0× 44 1.3k
S. Thoresen Norway 14 613 1.6× 100 0.4× 246 1.1× 300 1.5× 70 0.4× 21 939
Claude Hocké France 13 147 0.4× 213 0.9× 100 0.5× 83 0.4× 67 0.4× 52 628
Moni Roy United States 13 204 0.5× 424 1.8× 246 1.1× 224 1.1× 58 0.3× 52 995
Renê Faustino Gabriel France 14 788 2.1× 56 0.2× 413 1.9× 161 0.8× 250 1.4× 79 1.2k

Countries citing papers authored by Devansu Tewari

Since Specialization
Citations

This map shows the geographic impact of Devansu Tewari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devansu Tewari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devansu Tewari more than expected).

Fields of papers citing papers by Devansu Tewari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devansu Tewari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devansu Tewari. The network helps show where Devansu Tewari may publish in the future.

Co-authorship network of co-authors of Devansu Tewari

This figure shows the co-authorship network connecting the top 25 collaborators of Devansu Tewari. A scholar is included among the top collaborators of Devansu Tewari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devansu Tewari. Devansu Tewari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffman, Trevor L., et al.. (2025). Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System. JCO Oncology Practice. 21(9). 1296–1305. 2 indexed citations
2.
3.
Mittman, Brian S., Erin E. Hahn, Quyen Ngo‐Metzger, et al.. (2024). Primary Human Papillomavirus Screening: Women’s Perceptions of New Cervical Cancer Screening Recommendations. Journal of Women s Health. 33(12). 1614–1624. 1 indexed citations
4.
Chao, Chun, Erin E. Hahn, Devansu Tewari, et al.. (2022). A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemporary Clinical Trials. 124. 106994–106994. 1 indexed citations
5.
Hahn, Erin E., Corrine Munoz‐Plaza, Chunyi Hsu, et al.. (2021). De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. SHILAP Revista de lepidopterología. 2(1). 108–108. 10 indexed citations
6.
7.
Tewari, Devansu, Susan Novak-Weekley, Christina Hong, Shagufta Aslam, & Catherine Behrens. (2017). Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath. American Journal of Clinical Pathology. 148(5). 450–457. 7 indexed citations
8.
Tewari, Devansu, et al.. (2016). Targeted Treatment of a Rare Vaginal Sarcoma With an Anaplastic Lymphoma Kinase Inhibitor. Obstetrics and Gynecology. 127(2). 222–225. 1 indexed citations
9.
Tewari, Devansu, James Java, Ritu Salani, et al.. (2015). Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer. Obstetrical & Gynecological Survey. 70(8). 505–506. 2 indexed citations
10.
Tewari, Devansu, Vipin Kumar Singh, & Sanjeev K. Gautam. (2014). Clinical management of parturient haemoglobinuria in a buffalo (Bubalus bubalis).. Intas Polivet. 15(2). 528–530.
11.
Tewari, Devansu, et al.. (2007). Bevacizumab demonstrates activity in advanced refractory fallopian tube carcinoma. International Journal of Gynecological Cancer. 18(2). 369–372. 6 indexed citations
12.
Tewari, Devansu, et al.. (2006). Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma. Gynecologic Oncology. 102(3). 421–424. 15 indexed citations
13.
Tewari, Devansu, Bradley J. Monk, Muthana Al‐Ghazi, et al.. (2005). Gene expression profiling of in vitro radiation resistance in cervical carcinoma: A feasibility study. Gynecologic Oncology. 99(1). 84–91. 23 indexed citations
14.
Tewari, Devansu, et al.. (2004). Surgical Cytoreduction and Hormone Therapy of an Advanced Endometrial Stromal Sarcoma of the Ovary. Obstetrics and Gynecology. 103(5). 1051–1054. 14 indexed citations
15.
Tewari, Devansu, et al.. (2004). Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma. Investigational New Drugs. 22(4). 475–480. 20 indexed citations
16.
Tewari, Devansu, et al.. (2002). Primary Invasive Vaginal Cancer in the Setting of the Mayer–Rokitansky–Kuster–Hauser Syndrome. Gynecologic Oncology. 85(2). 384–387. 12 indexed citations
17.
Giordano, Ricardo J., David L. Fouts, Devansu Tewari, et al.. (1999). Cloning of a Surface Membrane Glycoprotein Specific for the Infective Form of Trypanosoma cruzi Having Adhesive Properties to Laminin. Journal of Biological Chemistry. 274(6). 3461–3468. 96 indexed citations
18.
Tewari, Devansu, et al.. (1998). The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. American Journal of Obstetrics and Gynecology. 178(6). 1116–1120. 48 indexed citations
19.
Cohen, Bruce E., et al.. (1997). Pregnancy complicated by vesical calculus and vesicocutaneous fistula. American Journal of Obstetrics and Gynecology. 176(3). 728–729. 9 indexed citations
20.
Ruef, Barbara J., et al.. (1994). Expression and evolution of members of the Trypanosoma cruzi trypomastigote surface antigen multigene family. Molecular and Biochemical Parasitology. 63(1). 109–120. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Ehlen Breakdown of academic impact, for papers by Mojca Eržen Breakdown of academic impact, for papers by Jean‐Jacques Baldauf Breakdown of academic impact, for papers by C. Meg McLachlin Breakdown of academic impact, for papers by Jan Pyman Breakdown of academic impact, for papers by Inger Gustavsson Breakdown of academic impact, for papers by S. Thoresen Breakdown of academic impact, for papers by Claude Hocké Breakdown of academic impact, for papers by Moni Roy Breakdown of academic impact, for papers by Renê Faustino Gabriel
Rankless by CCL
2026